Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial.

Göran M Ahlgren,Per Flodgren,Teuvo L J Tammela,Pirkko Kellokumpu-Lehtinen,Michael Borre,Anders Angelsen,Jon Reidar Iversen,Asgerdur Sverrisdottir,Eirikur Jonsson,Lisa Sengelov

European Urology（2018）

Cited 55|Views23

No score

Abstract

In this randomised trial, docetaxel without hormonal therapy or continuous corticosteroids was given after radical prostatectomy for high-risk prostate cancer. We found no benefit from docetaxel alone given after radical prostatectomy.

Translated text

Key words

Prostate cancer,Adjuvant,Docetaxel,Randomised trial,Radical prostatectomy

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined